Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

doi:10.1016/j.cell.2021.02.037

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

Cell - 29 Apr 2021

Zhou Daming, Dejnirattisai Wanwisa, Supasa Piyada, Liu Chang, Mentzer Alexander J, Ginn Helen M, Zhao Yuguang, Duyvesteyn Helen M E, Tuekprakhon Aekkachai, Nutalai Rungtiwa, Wang Beibei, Paesen Guido C, Lopez-Camacho Cesar, Slon-Campos Jose, Hallis Bassam, Coombes Naomi, Bewley Kevin, Charlton Sue, Walter Thomas S, Skelly Donal, Lumley Sheila F, Dold Christina, Levin Robert, Dong Tao, Pollard Andrew J, Knight Julian C, Crook Derrick, Lambe Teresa, Clutterbuck Elizabeth, Bibi Sagida, Flaxman Amy, Bittaye Mustapha, Belij-Rammerstorfer Sandra, Gilbert Sarah, James William, Carroll Miles W, Klenerman Paul, Barnes Eleanor, Dunachie Susanna J, Fry Elizabeth E, Mongkolsapaya Juthathip, Ren Jingshan, Stuart David I, Screaton Gavin R

Abstract excerpt

The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began when the first sequence was published, and this forms the basis for vaccines currently deployed globally. Independent lineages of SARS-CoV-2 have recently been reported: UK, B.1.1.7; South Africa, B.1.351; and Brazil, P.1. These variants have multiple changes in the immunodominant spike protein that facilitates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chlorocebus aethiops

Share to Clinical Trials as Topic

Share to COVID-19

Share to COVID-19 Vaccines

Share to Immunization, Passive

Share to Neutralization Tests

Share to SARS-CoV-2

Share to Vero Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 33730597
DOI: 10.1016/j.cell.2021.02.037
PMCID: PMC7901269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.PMID 33730597Read ↗

Antibody evasion by the P.1 strain of SARS-CoV-2.Semantic proximity Read ↗

Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.Semantic proximity Read ↗

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity Read ↗

SARS-COV-2 Variants: Differences and Potential of Immune Evasion.Semantic proximity Read ↗

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read ↗

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.Semantic proximity Read ↗

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.Semantic proximity Read ↗

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variantsSemantic proximity Read ↗

Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing AntibodiesSemantic proximity Read ↗

Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries.Semantic proximity Read ↗

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding.Semantic proximity Read ↗

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.